329 related articles for article (PubMed ID: 37097160)
1. Identification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineering.
Esquerra-Ruvira B; Baquedano I; Ruiz R; Fernandez A; Montoliu L; Mojica FJM
Microb Biotechnol; 2023 Jul; 16(7):1505-1523. PubMed ID: 37097160
[TBL] [Abstract][Full Text] [Related]
2. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene disruption by CRISPR/xCas9 system in Drosophila melanogaster.
Ni XY; Zhou ZD; Huang J; Qiao X
Arch Insect Biochem Physiol; 2020 May; 104(1):e21662. PubMed ID: 32027059
[TBL] [Abstract][Full Text] [Related]
4. Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM.
Liu Y; Liang F; Dong Z; Li S; Ye J; Qin W
Cells; 2021 Aug; 10(8):. PubMed ID: 34440868
[TBL] [Abstract][Full Text] [Related]
5. Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.
Mekler V; Kuznedelov K; Severinov K
J Biol Chem; 2020 May; 295(19):6509-6517. PubMed ID: 32241913
[TBL] [Abstract][Full Text] [Related]
6. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
Briner AE; Henriksen ED; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.
Hirano S; Nishimasu H; Ishitani R; Nureki O
Mol Cell; 2016 Mar; 61(6):886-94. PubMed ID: 26990991
[TBL] [Abstract][Full Text] [Related]
8. Identification of RNA Binding Partners of CRISPR-Cas Proteins in Prokaryotes Using RIP-Seq.
Sharma S; Sharma CM
Methods Mol Biol; 2022; 2404():111-133. PubMed ID: 34694606
[TBL] [Abstract][Full Text] [Related]
9. PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells.
Fedorova I; Vasileva A; Selkova P; Abramova M; Arseniev A; Pobegalov G; Kazalov M; Musharova O; Goryanin I; Artamonova D; Zyubko T; Shmakov S; Artamonova T; Khodorkovskii M; Severinov K
Nucleic Acids Res; 2020 Dec; 48(21):12297-12309. PubMed ID: 33152077
[TBL] [Abstract][Full Text] [Related]
10. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
11. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
[TBL] [Abstract][Full Text] [Related]
12. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
Zhang D; Zhang B
Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
[TBL] [Abstract][Full Text] [Related]
13. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
Briner AE; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
[TBL] [Abstract][Full Text] [Related]
14. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas nucleases and base editors for plant genome editing.
Gürel F; Zhang Y; Sretenovic S; Qi Y
aBIOTECH; 2020 Jan; 1(1):74-87. PubMed ID: 36305010
[TBL] [Abstract][Full Text] [Related]
16. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into a high fidelity variant of SpCas9.
Guo M; Ren K; Zhu Y; Tang Z; Wang Y; Zhang B; Huang Z
Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728
[TBL] [Abstract][Full Text] [Related]
18. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
Hua K; Tao X; Han P; Wang R; Zhu JK
Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
[TBL] [Abstract][Full Text] [Related]
19. Can SpRY recognize any PAM in human cells?
Ye J; Xi H; Chen Y; Chen Q; Lu X; Lv J; Chen Y; Gu F; Zhao J
J Zhejiang Univ Sci B; 2022 May; 23(5):382-391. PubMed ID: 35557039
[TBL] [Abstract][Full Text] [Related]
20. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]